Canadian boost for UCalgary racehorse injury prevention research will have global benefits

Professor Thilo Pfau of the University of Calgary demonstrated the use of wearable sensors at the Rood & Riddle International Equine Podiatry Conference in 2022. This horse was subjected to before/after  analysis as farriers and veterinarians used imaging, trimming, and shoeing methods to help the horse. (Hoof Blog file photo)

Horse Racing Alberta invests in racehorse injury prevention research with $185,000 donation to University of Calgary program led by Dr. Thilo Pfau.

 

Canada's Horse Racing Alberta (HRA) has generously committed $185,000 to support pioneering research by Dr. Thilo Pfau and his team at the University of Calgary’s Faculty of Veterinary Medicine and Faculty of Kinesiology. This significant contribution will fund research aimed at improving the prediction and prevention of racehorse injuries, a critical area of focus for the safety and protection of equine athletes.

Beyond Navicular Disease: Racing Commissioners Call for Regulation of Bisphosphonates in Sale Horses

Portions of the following information is edited from a press release:

The Association of Racing Commissioners International (ARCI) is formally calling for the independent regulation of the breeding and sales industries, including regulation of the class of drugs known as bisphosphonates, which are approved by the US Food and Drug Administration (FDA) for the treatment of navicular disease.